Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Nengwei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9412-2652; OpenAlex author ID A5052753033. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 4

  1. PLIN5 affects the fibrosis and progression of pancreatic cancer via modulation of pancreatic stellate cells. Co-author DOI 10.1016/j.lfs.2025.124060↗
  2. Cancer-associated fibroblast-derived MMP11 promotes tumor progression in pancreatic cancer. Co-author DOI 10.1111/cas.16418↗
  3. MSLN induced EMT, cancer stem cell traits and chemotherapy resistance of pancreatic cancer cells. Co-author DOI 10.1016/j.heliyon.2024.e29210↗
  4. The detail of the en bloc technique and prognosis of spleen-preserving laparoscopic distal pancreatectomy for pancreatic cancer. Last author DOI 10.1186/s12957-015-0735-y↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bin Zhu · 3 shared papers, 2024–2025 · strength 0.73
  2. Zhuoyin Wang · 2 shared papers, 2025 · strength 0.54
  3. Jili Hu · 2 shared papers, 2024–2025 · strength 0.46
  4. Xu Guo · 1 shared paper, 2025 · strength 0.27
  5. Jing Wang · 1 shared paper, 2025 · strength 0.27
  6. Zhipeng Sun · 1 shared paper, 2015 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.